|
1.19
|
1.06e-85
|
GO:0009987
|
cellular process
|
|
1.24
|
7.39e-56
|
GO:0065007
|
biological regulation
|
|
1.24
|
6.72e-52
|
GO:0050789
|
regulation of biological process
|
|
1.25
|
4.29e-49
|
GO:0050794
|
regulation of cellular process
|
|
1.36
|
1.95e-41
|
GO:0032502
|
developmental process
|
|
1.38
|
4.16e-41
|
GO:0007275
|
multicellular organismal development
|
|
1.39
|
1.39e-38
|
GO:0048856
|
anatomical structure development
|
|
1.42
|
1.21e-37
|
GO:0048518
|
positive regulation of biological process
|
|
1.34
|
1.76e-37
|
GO:0023052
|
signaling
|
|
1.41
|
2.82e-37
|
GO:0048731
|
system development
|
|
1.23
|
1.20e-35
|
GO:0044237
|
cellular metabolic process
|
|
1.23
|
5.31e-35
|
GO:0044238
|
primary metabolic process
|
|
1.57
|
1.63e-34
|
GO:0007399
|
nervous system development
|
|
1.34
|
3.11e-34
|
GO:0071840
|
cellular component organization or biogenesis
|
|
1.35
|
3.16e-34
|
GO:0016043
|
cellular component organization
|
|
1.20
|
7.63e-34
|
GO:0008152
|
metabolic process
|
|
1.46
|
7.87e-34
|
GO:0048523
|
negative regulation of cellular process
|
|
1.43
|
8.01e-34
|
GO:0048519
|
negative regulation of biological process
|
|
1.42
|
2.31e-32
|
GO:0048522
|
positive regulation of cellular process
|
|
1.26
|
2.92e-31
|
GO:0043170
|
macromolecule metabolic process
|
|
1.29
|
1.14e-29
|
GO:0051716
|
cellular response to stimulus
|
|
1.32
|
8.72e-29
|
GO:0007165
|
signal transduction
|
|
1.27
|
2.11e-28
|
GO:0044260
|
cellular macromolecule metabolic process
|
|
1.51
|
2.25e-27
|
GO:0009653
|
anatomical structure morphogenesis
|
|
1.41
|
1.78e-26
|
GO:0065008
|
regulation of biological quality
|
|
1.35
|
5.12e-25
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
|
1.35
|
7.94e-25
|
GO:0071842
|
cellular component organization at cellular level
|
|
1.39
|
1.10e-23
|
GO:0048869
|
cellular developmental process
|
|
1.40
|
1.48e-23
|
GO:0030154
|
cell differentiation
|
|
1.61
|
7.63e-23
|
GO:0022008
|
neurogenesis
|
|
1.63
|
9.59e-23
|
GO:0048699
|
generation of neurons
|
|
1.54
|
1.02e-22
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
|
1.50
|
6.87e-22
|
GO:0009893
|
positive regulation of metabolic process
|
|
1.25
|
1.25e-20
|
GO:0019222
|
regulation of metabolic process
|
|
1.27
|
1.66e-20
|
GO:0031323
|
regulation of cellular metabolic process
|
|
1.27
|
3.33e-20
|
GO:0080090
|
regulation of primary metabolic process
|
|
1.67
|
4.83e-20
|
GO:0030182
|
neuron differentiation
|
|
1.49
|
1.14e-19
|
GO:0031325
|
positive regulation of cellular metabolic process
|
|
1.28
|
1.44e-19
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
|
1.27
|
1.98e-19
|
GO:0006807
|
nitrogen compound metabolic process
|
|
1.17
|
1.04e-18
|
GO:0050896
|
response to stimulus
|
|
1.30
|
1.39e-18
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.26
|
2.05e-18
|
GO:0060255
|
regulation of macromolecule metabolic process
|
|
1.58
|
3.20e-18
|
GO:0051128
|
regulation of cellular component organization
|
|
1.33
|
4.03e-18
|
GO:0042221
|
response to chemical stimulus
|
|
1.53
|
5.13e-18
|
GO:0009892
|
negative regulation of metabolic process
|
|
1.19
|
6.56e-18
|
GO:0032501
|
multicellular organismal process
|
|
1.52
|
1.54e-17
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
|
1.54
|
1.67e-17
|
GO:0048468
|
cell development
|
|
1.53
|
1.02e-16
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
|
1.35
|
1.23e-16
|
GO:0048513
|
organ development
|
|
1.62
|
1.74e-16
|
GO:0051254
|
positive regulation of RNA metabolic process
|
|
1.62
|
1.94e-16
|
GO:0010628
|
positive regulation of gene expression
|
|
1.64
|
2.55e-16
|
GO:0032989
|
cellular component morphogenesis
|
|
1.72
|
2.80e-16
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
|
1.43
|
3.25e-16
|
GO:0051239
|
regulation of multicellular organismal process
|
|
1.67
|
3.29e-16
|
GO:0048666
|
neuron development
|
|
1.52
|
3.79e-16
|
GO:0031324
|
negative regulation of cellular metabolic process
|
|
1.53
|
5.12e-16
|
GO:0006351
|
transcription, DNA-dependent
|
|
1.24
|
8.69e-16
|
GO:0051179
|
localization
|
|
1.64
|
2.06e-15
|
GO:0000902
|
cell morphogenesis
|
|
1.49
|
2.51e-15
|
GO:0032774
|
RNA biosynthetic process
|
|
1.30
|
2.53e-15
|
GO:0044249
|
cellular biosynthetic process
|
|
1.56
|
2.57e-15
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.55
|
3.21e-15
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
|
1.46
|
4.76e-15
|
GO:0051246
|
regulation of protein metabolic process
|
|
1.26
|
6.54e-15
|
GO:0019538
|
protein metabolic process
|
|
1.36
|
8.79e-15
|
GO:0023051
|
regulation of signaling
|
|
1.69
|
1.09e-14
|
GO:0031175
|
neuron projection development
|
|
1.52
|
1.35e-14
|
GO:0009891
|
positive regulation of biosynthetic process
|
|
1.52
|
1.95e-14
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
|
1.28
|
1.99e-14
|
GO:0009058
|
biosynthetic process
|
|
1.61
|
2.61e-14
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
|
1.71
|
1.02e-13
|
GO:0048812
|
neuron projection morphogenesis
|
|
1.34
|
1.25e-13
|
GO:0009059
|
macromolecule biosynthetic process
|
|
1.35
|
1.42e-13
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
|
1.71
|
1.48e-13
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
|
1.34
|
1.79e-13
|
GO:0016070
|
RNA metabolic process
|
|
1.58
|
2.41e-13
|
GO:0030030
|
cell projection organization
|
|
1.46
|
2.61e-13
|
GO:0009605
|
response to external stimulus
|
|
1.45
|
2.64e-13
|
GO:0007154
|
cell communication
|
|
1.45
|
2.64e-13
|
GO:0032268
|
regulation of cellular protein metabolic process
|
|
1.44
|
3.19e-13
|
GO:0010941
|
regulation of cell death
|
|
1.44
|
3.21e-13
|
GO:0043067
|
regulation of programmed cell death
|
|
1.32
|
3.32e-13
|
GO:0010467
|
gene expression
|
|
1.44
|
3.93e-13
|
GO:0042981
|
regulation of apoptosis
|
|
1.25
|
5.27e-13
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
|
1.47
|
5.32e-13
|
GO:0050793
|
regulation of developmental process
|
|
1.53
|
6.39e-13
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
|
1.32
|
6.41e-13
|
GO:0006464
|
protein modification process
|
|
1.71
|
7.44e-13
|
GO:0007409
|
axonogenesis
|
|
1.36
|
7.49e-13
|
GO:0065009
|
regulation of molecular function
|
|
1.26
|
7.63e-13
|
GO:0009889
|
regulation of biosynthetic process
|
|
1.27
|
8.17e-13
|
GO:0006950
|
response to stress
|
|
1.31
|
1.02e-12
|
GO:0048583
|
regulation of response to stimulus
|
|
1.27
|
1.35e-12
|
GO:0044267
|
cellular protein metabolic process
|
|
1.64
|
1.50e-12
|
GO:0048858
|
cell projection morphogenesis
|
|
1.25
|
1.51e-12
|
GO:0031326
|
regulation of cellular biosynthetic process
|
|
1.63
|
2.13e-12
|
GO:0032990
|
cell part morphogenesis
|
|
1.28
|
2.58e-12
|
GO:0090304
|
nucleic acid metabolic process
|
|
1.53
|
4.45e-12
|
GO:0009890
|
negative regulation of biosynthetic process
|
|
1.49
|
4.87e-12
|
GO:0031399
|
regulation of protein modification process
|
|
1.44
|
6.25e-12
|
GO:0032879
|
regulation of localization
|
|
1.54
|
7.86e-12
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
|
1.31
|
1.08e-11
|
GO:0007166
|
cell surface receptor linked signaling pathway
|
|
1.25
|
1.51e-11
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.33
|
1.64e-11
|
GO:0006996
|
organelle organization
|
|
1.50
|
1.83e-11
|
GO:2000026
|
regulation of multicellular organismal development
|
|
1.76
|
1.96e-11
|
GO:0032535
|
regulation of cellular component size
|
|
1.46
|
1.98e-11
|
GO:0040011
|
locomotion
|
|
1.52
|
2.47e-11
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
|
1.60
|
2.93e-11
|
GO:0007417
|
central nervous system development
|
|
1.52
|
6.34e-11
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
|
1.54
|
6.46e-11
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
|
1.25
|
6.57e-11
|
GO:0010468
|
regulation of gene expression
|
|
1.34
|
7.02e-11
|
GO:0009966
|
regulation of signal transduction
|
|
1.22
|
7.99e-11
|
GO:0006810
|
transport
|
|
1.22
|
8.17e-11
|
GO:0051234
|
establishment of localization
|
|
1.44
|
1.77e-10
|
GO:0008219
|
cell death
|
|
1.25
|
1.90e-10
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
|
1.44
|
2.15e-10
|
GO:0016265
|
death
|
|
1.50
|
2.35e-10
|
GO:0009790
|
embryo development
|
|
1.28
|
2.67e-10
|
GO:0043412
|
macromolecule modification
|
|
1.47
|
3.57e-10
|
GO:0007267
|
cell-cell signaling
|
|
1.24
|
3.60e-10
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
|
1.55
|
5.41e-10
|
GO:0051253
|
negative regulation of RNA metabolic process
|
|
1.52
|
5.72e-10
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
|
1.52
|
6.75e-10
|
GO:0010629
|
negative regulation of gene expression
|
|
1.51
|
7.50e-10
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
|
1.56
|
7.78e-10
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
|
1.25
|
7.81e-10
|
GO:0051252
|
regulation of RNA metabolic process
|
|
1.49
|
8.04e-10
|
GO:0045595
|
regulation of cell differentiation
|
|
1.67
|
8.66e-10
|
GO:0090066
|
regulation of anatomical structure size
|
|
1.40
|
1.03e-09
|
GO:0042127
|
regulation of cell proliferation
|
|
1.50
|
1.56e-09
|
GO:0001932
|
regulation of protein phosphorylation
|
|
1.57
|
1.66e-09
|
GO:0019226
|
transmission of nerve impulse
|
|
1.57
|
1.66e-09
|
GO:0035637
|
multicellular organismal signaling
|
|
1.39
|
2.16e-09
|
GO:0006793
|
phosphorus metabolic process
|
|
1.39
|
2.16e-09
|
GO:0006796
|
phosphate metabolic process
|
|
1.83
|
2.90e-09
|
GO:0051129
|
negative regulation of cellular component organization
|
|
1.37
|
5.00e-09
|
GO:0010646
|
regulation of cell communication
|
|
1.68
|
5.65e-09
|
GO:0007411
|
axon guidance
|
|
1.45
|
5.79e-09
|
GO:0006468
|
protein phosphorylation
|
|
1.46
|
8.18e-09
|
GO:0019220
|
regulation of phosphate metabolic process
|
|
1.46
|
8.18e-09
|
GO:0051174
|
regulation of phosphorus metabolic process
|
|
1.58
|
8.83e-09
|
GO:0051094
|
positive regulation of developmental process
|
|
1.32
|
9.02e-09
|
GO:0035556
|
intracellular signal transduction
|
|
1.54
|
1.06e-08
|
GO:0006935
|
chemotaxis
|
|
1.54
|
1.06e-08
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
|
1.54
|
1.06e-08
|
GO:0042330
|
taxis
|
|
1.46
|
1.45e-08
|
GO:0042325
|
regulation of phosphorylation
|
|
1.75
|
2.26e-08
|
GO:0008361
|
regulation of cell size
|
|
2.08
|
3.68e-08
|
GO:0010639
|
negative regulation of organelle organization
|
|
1.24
|
4.08e-08
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
|
1.53
|
4.41e-08
|
GO:0007010
|
cytoskeleton organization
|
|
1.56
|
5.38e-08
|
GO:0007268
|
synaptic transmission
|
|
1.54
|
6.03e-08
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
|
1.31
|
1.48e-07
|
GO:0010033
|
response to organic substance
|
|
1.57
|
1.62e-07
|
GO:0051247
|
positive regulation of protein metabolic process
|
|
1.65
|
2.11e-07
|
GO:0031401
|
positive regulation of protein modification process
|
|
1.32
|
2.21e-07
|
GO:0044085
|
cellular component biogenesis
|
|
1.32
|
2.54e-07
|
GO:0050790
|
regulation of catalytic activity
|
|
1.39
|
2.97e-07
|
GO:0033554
|
cellular response to stress
|
|
1.53
|
3.16e-07
|
GO:0008283
|
cell proliferation
|
|
1.52
|
4.60e-07
|
GO:0072358
|
cardiovascular system development
|
|
1.52
|
4.60e-07
|
GO:0072359
|
circulatory system development
|
|
1.34
|
4.72e-07
|
GO:0022607
|
cellular component assembly
|
|
1.40
|
5.21e-07
|
GO:0016192
|
vesicle-mediated transport
|
|
1.41
|
5.49e-07
|
GO:0012501
|
programmed cell death
|
|
1.45
|
5.85e-07
|
GO:0009725
|
response to hormone stimulus
|
|
1.41
|
8.05e-07
|
GO:0006915
|
apoptosis
|
|
1.37
|
9.65e-07
|
GO:0016310
|
phosphorylation
|
|
1.36
|
1.33e-06
|
GO:0042592
|
homeostatic process
|
|
1.56
|
1.43e-06
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
|
1.38
|
1.44e-06
|
GO:0044093
|
positive regulation of molecular function
|
|
1.31
|
1.49e-06
|
GO:0044248
|
cellular catabolic process
|
|
1.57
|
2.27e-06
|
GO:0007420
|
brain development
|
|
1.50
|
2.92e-06
|
GO:0060548
|
negative regulation of cell death
|
|
2.05
|
3.10e-06
|
GO:0006836
|
neurotransmitter transport
|
|
1.54
|
3.15e-06
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
|
1.29
|
3.25e-06
|
GO:0051641
|
cellular localization
|
|
2.13
|
3.60e-06
|
GO:0001505
|
regulation of neurotransmitter levels
|
|
2.35
|
3.69e-06
|
GO:0007269
|
neurotransmitter secretion
|
|
1.65
|
3.96e-06
|
GO:0001568
|
blood vessel development
|
|
1.47
|
4.47e-06
|
GO:0043068
|
positive regulation of programmed cell death
|
|
1.40
|
5.30e-06
|
GO:0009719
|
response to endogenous stimulus
|
|
1.58
|
5.46e-06
|
GO:0044057
|
regulation of system process
|
|
1.62
|
6.17e-06
|
GO:0030029
|
actin filament-based process
|
|
1.63
|
6.45e-06
|
GO:0035295
|
tube development
|
|
1.51
|
7.41e-06
|
GO:0008285
|
negative regulation of cell proliferation
|
|
1.38
|
7.85e-06
|
GO:0051049
|
regulation of transport
|
|
1.60
|
8.01e-06
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
|
1.58
|
8.07e-06
|
GO:0033043
|
regulation of organelle organization
|
|
1.50
|
8.08e-06
|
GO:0046903
|
secretion
|
|
1.46
|
8.12e-06
|
GO:0043065
|
positive regulation of apoptosis
|
|
1.45
|
8.34e-06
|
GO:0044092
|
negative regulation of molecular function
|
|
1.65
|
9.05e-06
|
GO:0051248
|
negative regulation of protein metabolic process
|
|
1.58
|
9.19e-06
|
GO:0060284
|
regulation of cell development
|
|
1.50
|
9.74e-06
|
GO:0032583
|
regulation of gene-specific transcription
|
|
1.66
|
1.05e-05
|
GO:0030036
|
actin cytoskeleton organization
|
|
1.50
|
1.12e-05
|
GO:0040008
|
regulation of growth
|
|
1.42
|
1.23e-05
|
GO:0009887
|
organ morphogenesis
|
|
1.44
|
1.25e-05
|
GO:0019725
|
cellular homeostasis
|
|
1.49
|
1.48e-05
|
GO:0043066
|
negative regulation of apoptosis
|
|
1.56
|
1.79e-05
|
GO:0045597
|
positive regulation of cell differentiation
|
|
1.48
|
1.86e-05
|
GO:0043069
|
negative regulation of programmed cell death
|
|
1.44
|
2.20e-05
|
GO:0010942
|
positive regulation of cell death
|
|
1.23
|
2.33e-05
|
GO:0044281
|
small molecule metabolic process
|
|
1.59
|
2.38e-05
|
GO:0006366
|
transcription from RNA polymerase II promoter
|
|
1.58
|
2.71e-05
|
GO:0009141
|
nucleoside triphosphate metabolic process
|
|
1.60
|
3.03e-05
|
GO:0061061
|
muscle structure development
|
|
1.49
|
3.22e-05
|
GO:0007243
|
intracellular protein kinase cascade
|
|
1.49
|
3.22e-05
|
GO:0023014
|
signal transduction via phosphorylation event
|
|
1.59
|
3.51e-05
|
GO:0001944
|
vasculature development
|
|
1.46
|
3.74e-05
|
GO:0045859
|
regulation of protein kinase activity
|
|
1.63
|
3.95e-05
|
GO:0000165
|
MAPKKK cascade
|
|
1.33
|
3.99e-05
|
GO:0009888
|
tissue development
|
|
1.25
|
4.65e-05
|
GO:0009056
|
catabolic process
|
|
1.57
|
4.96e-05
|
GO:0009199
|
ribonucleoside triphosphate metabolic process
|
|
1.34
|
5.32e-05
|
GO:0048584
|
positive regulation of response to stimulus
|
|
1.59
|
5.41e-05
|
GO:0071900
|
regulation of protein serine/threonine kinase activity
|
|
1.29
|
5.79e-05
|
GO:0051649
|
establishment of localization in cell
|
|
1.63
|
6.16e-05
|
GO:0032269
|
negative regulation of cellular protein metabolic process
|
|
1.57
|
7.93e-05
|
GO:0009205
|
purine ribonucleoside triphosphate metabolic process
|
|
1.43
|
8.34e-05
|
GO:0051338
|
regulation of transferase activity
|
|
1.63
|
9.61e-05
|
GO:0001558
|
regulation of cell growth
|
|
1.41
|
9.62e-05
|
GO:0006928
|
cellular component movement
|
|
1.36
|
1.03e-04
|
GO:0043085
|
positive regulation of catalytic activity
|
|
1.70
|
1.20e-04
|
GO:0010562
|
positive regulation of phosphorus metabolic process
|
|
1.70
|
1.20e-04
|
GO:0045937
|
positive regulation of phosphate metabolic process
|
|
1.67
|
1.35e-04
|
GO:0043405
|
regulation of MAP kinase activity
|
|
1.74
|
1.60e-04
|
GO:0001934
|
positive regulation of protein phosphorylation
|
|
1.55
|
1.67e-04
|
GO:0009144
|
purine nucleoside triphosphate metabolic process
|
|
1.48
|
1.90e-04
|
GO:0006163
|
purine nucleotide metabolic process
|
|
1.42
|
2.11e-04
|
GO:0006753
|
nucleoside phosphate metabolic process
|
|
1.42
|
2.11e-04
|
GO:0009117
|
nucleotide metabolic process
|
|
2.23
|
2.11e-04
|
GO:0051494
|
negative regulation of cytoskeleton organization
|
|
1.54
|
2.13e-04
|
GO:0048729
|
tissue morphogenesis
|
|
1.42
|
2.14e-04
|
GO:0043549
|
regulation of kinase activity
|
|
1.69
|
2.60e-04
|
GO:0042327
|
positive regulation of phosphorylation
|
|
1.66
|
2.87e-04
|
GO:0044087
|
regulation of cellular component biogenesis
|
|
1.26
|
2.87e-04
|
GO:0002376
|
immune system process
|
|
1.44
|
3.13e-04
|
GO:0061024
|
membrane organization
|
|
1.48
|
3.34e-04
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
|
1.33
|
3.35e-04
|
GO:0071844
|
cellular component assembly at cellular level
|
|
1.36
|
3.43e-04
|
GO:0071310
|
cellular response to organic substance
|
|
1.45
|
3.71e-04
|
GO:0043086
|
negative regulation of catalytic activity
|
|
1.44
|
3.75e-04
|
GO:0006873
|
cellular ion homeostasis
|
|
1.43
|
3.78e-04
|
GO:0016044
|
cellular membrane organization
|
|
1.37
|
3.81e-04
|
GO:0048878
|
chemical homeostasis
|
|
1.54
|
3.89e-04
|
GO:0051270
|
regulation of cellular component movement
|
|
1.72
|
4.45e-04
|
GO:0031400
|
negative regulation of protein modification process
|
|
1.58
|
4.90e-04
|
GO:0050767
|
regulation of neurogenesis
|
|
1.48
|
4.96e-04
|
GO:0043009
|
chordate embryonic development
|
|
1.50
|
5.28e-04
|
GO:0009259
|
ribonucleotide metabolic process
|
|
1.53
|
5.35e-04
|
GO:0051130
|
positive regulation of cellular component organization
|
|
1.43
|
5.52e-04
|
GO:0055082
|
cellular chemical homeostasis
|
|
1.48
|
5.98e-04
|
GO:0044419
|
interspecies interaction between organisms
|
|
1.47
|
6.11e-04
|
GO:0048598
|
embryonic morphogenesis
|
|
1.51
|
6.12e-04
|
GO:0009150
|
purine ribonucleotide metabolic process
|
|
1.45
|
6.56e-04
|
GO:0009968
|
negative regulation of signal transduction
|
|
1.37
|
6.90e-04
|
GO:0042060
|
wound healing
|
|
1.65
|
7.05e-04
|
GO:0048732
|
gland development
|
|
1.24
|
7.17e-04
|
GO:0033036
|
macromolecule localization
|
|
1.36
|
8.26e-04
|
GO:0051726
|
regulation of cell cycle
|
|
1.48
|
8.39e-04
|
GO:0007389
|
pattern specification process
|
|
1.63
|
8.64e-04
|
GO:0045664
|
regulation of neuron differentiation
|
|
1.61
|
8.74e-04
|
GO:0048514
|
blood vessel morphogenesis
|
|
1.51
|
8.85e-04
|
GO:0032870
|
cellular response to hormone stimulus
|
|
1.84
|
8.95e-04
|
GO:0045792
|
negative regulation of cell size
|
|
1.58
|
8.98e-04
|
GO:0006897
|
endocytosis
|
|
1.58
|
8.98e-04
|
GO:0010324
|
membrane invagination
|
|
1.69
|
9.35e-04
|
GO:0051493
|
regulation of cytoskeleton organization
|
|
1.49
|
9.68e-04
|
GO:0051098
|
regulation of binding
|
|
1.42
|
9.68e-04
|
GO:0023057
|
negative regulation of signaling
|
|
1.40
|
1.07e-03
|
GO:0001775
|
cell activation
|
|
1.41
|
1.13e-03
|
GO:0050801
|
ion homeostasis
|
|
1.42
|
1.16e-03
|
GO:0010648
|
negative regulation of cell communication
|
|
1.55
|
1.18e-03
|
GO:0030334
|
regulation of cell migration
|
|
1.86
|
1.20e-03
|
GO:0030308
|
negative regulation of cell growth
|
|
1.46
|
1.35e-03
|
GO:0016568
|
chromatin modification
|
|
1.29
|
1.62e-03
|
GO:0009611
|
response to wounding
|
|
1.79
|
1.76e-03
|
GO:0010959
|
regulation of metal ion transport
|
|
1.48
|
1.86e-03
|
GO:0071495
|
cellular response to endogenous stimulus
|
|
1.66
|
1.88e-03
|
GO:0030900
|
forebrain development
|
|
1.73
|
2.00e-03
|
GO:0045926
|
negative regulation of growth
|
|
1.42
|
2.04e-03
|
GO:0072521
|
purine-containing compound metabolic process
|
|
1.42
|
2.06e-03
|
GO:0016477
|
cell migration
|
|
1.49
|
2.13e-03
|
GO:0032940
|
secretion by cell
|
|
1.28
|
2.42e-03
|
GO:0070887
|
cellular response to chemical stimulus
|
|
1.53
|
2.42e-03
|
GO:2000145
|
regulation of cell motility
|
|
1.29
|
2.51e-03
|
GO:0043933
|
macromolecular complex subunit organization
|
|
1.52
|
2.55e-03
|
GO:0051101
|
regulation of DNA binding
|
|
1.82
|
2.65e-03
|
GO:0031098
|
stress-activated protein kinase signaling cascade
|
|
1.38
|
3.00e-03
|
GO:0048585
|
negative regulation of response to stimulus
|
|
1.49
|
3.10e-03
|
GO:0051329
|
interphase of mitotic cell cycle
|
|
1.36
|
3.35e-03
|
GO:0055086
|
nucleobase, nucleoside and nucleotide metabolic process
|
|
1.73
|
3.60e-03
|
GO:0060537
|
muscle tissue development
|
|
1.37
|
3.92e-03
|
GO:0008284
|
positive regulation of cell proliferation
|
|
1.50
|
4.20e-03
|
GO:0051960
|
regulation of nervous system development
|
|
1.40
|
4.21e-03
|
GO:0060341
|
regulation of cellular localization
|
|
1.38
|
4.30e-03
|
GO:0070271
|
protein complex biogenesis
|
|
1.44
|
4.37e-03
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
|
1.39
|
4.69e-03
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
|
1.33
|
4.73e-03
|
GO:0009057
|
macromolecule catabolic process
|
|
1.39
|
4.73e-03
|
GO:0048870
|
cell motility
|
|
1.39
|
4.73e-03
|
GO:0051674
|
localization of cell
|
|
1.48
|
4.80e-03
|
GO:0051325
|
interphase
|
|
1.47
|
4.95e-03
|
GO:0001501
|
skeletal system development
|
|
1.47
|
4.95e-03
|
GO:0009991
|
response to extracellular stimulus
|
|
1.45
|
5.23e-03
|
GO:0018193
|
peptidyl-amino acid modification
|
|
1.66
|
5.38e-03
|
GO:0071496
|
cellular response to external stimulus
|
|
1.55
|
5.61e-03
|
GO:0002009
|
morphogenesis of an epithelium
|
|
1.25
|
5.71e-03
|
GO:0007049
|
cell cycle
|
|
1.68
|
5.77e-03
|
GO:0031344
|
regulation of cell projection organization
|
|
1.70
|
6.09e-03
|
GO:0043406
|
positive regulation of MAP kinase activity
|
|
1.50
|
6.31e-03
|
GO:0048545
|
response to steroid hormone stimulus
|
|
1.74
|
6.45e-03
|
GO:0010975
|
regulation of neuron projection development
|
|
1.48
|
6.90e-03
|
GO:0031667
|
response to nutrient levels
|
|
1.34
|
7.05e-03
|
GO:0050878
|
regulation of body fluid levels
|
|
1.47
|
7.06e-03
|
GO:0030003
|
cellular cation homeostasis
|
|
1.46
|
7.48e-03
|
GO:0051093
|
negative regulation of developmental process
|
|
1.50
|
7.72e-03
|
GO:0006875
|
cellular metal ion homeostasis
|
|
1.59
|
7.79e-03
|
GO:0007517
|
muscle organ development
|
|
1.72
|
7.97e-03
|
GO:0030111
|
regulation of Wnt receptor signaling pathway
|
|
1.49
|
8.09e-03
|
GO:0055065
|
metal ion homeostasis
|
|
1.28
|
9.03e-03
|
GO:0006508
|
proteolysis
|
|
1.33
|
9.87e-03
|
GO:0071822
|
protein complex subunit organization
|
|
1.36
|
1.17e-02
|
GO:0006461
|
protein complex assembly
|
|
1.72
|
1.26e-02
|
GO:0010769
|
regulation of cell morphogenesis involved in differentiation
|
|
1.77
|
1.29e-02
|
GO:0003001
|
generation of a signal involved in cell-cell signaling
|
|
1.77
|
1.29e-02
|
GO:0023061
|
signal release
|
|
1.24
|
1.40e-02
|
GO:0008104
|
protein localization
|
|
1.30
|
1.41e-02
|
GO:0065003
|
macromolecular complex assembly
|
|
1.47
|
1.54e-02
|
GO:0040012
|
regulation of locomotion
|
|
1.70
|
1.75e-02
|
GO:0022604
|
regulation of cell morphogenesis
|
|
1.35
|
1.79e-02
|
GO:0009967
|
positive regulation of signal transduction
|
|
1.75
|
1.83e-02
|
GO:0000187
|
activation of MAPK activity
|
|
1.77
|
2.05e-02
|
GO:0001822
|
kidney development
|
|
1.65
|
2.08e-02
|
GO:0001655
|
urogenital system development
|
|
1.34
|
2.12e-02
|
GO:0044265
|
cellular macromolecule catabolic process
|
|
2.44
|
2.13e-02
|
GO:0060443
|
mammary gland morphogenesis
|
|
1.42
|
2.38e-02
|
GO:0044257
|
cellular protein catabolic process
|
|
1.42
|
2.38e-02
|
GO:0043434
|
response to peptide hormone stimulus
|
|
1.60
|
2.38e-02
|
GO:0071902
|
positive regulation of protein serine/threonine kinase activity
|
|
1.43
|
2.39e-02
|
GO:0055080
|
cation homeostasis
|
|
1.77
|
2.58e-02
|
GO:0032956
|
regulation of actin cytoskeleton organization
|
|
1.39
|
2.64e-02
|
GO:0007264
|
small GTPase mediated signal transduction
|
|
1.30
|
2.69e-02
|
GO:0046483
|
heterocycle metabolic process
|
|
1.47
|
2.70e-02
|
GO:0007346
|
regulation of mitotic cell cycle
|
|
1.46
|
2.75e-02
|
GO:0010035
|
response to inorganic substance
|
|
1.40
|
2.77e-02
|
GO:0030163
|
protein catabolic process
|
|
1.43
|
2.88e-02
|
GO:0051050
|
positive regulation of transport
|
|
1.75
|
2.91e-02
|
GO:0032970
|
regulation of actin filament-based process
|
|
1.90
|
3.22e-02
|
GO:0022612
|
gland morphogenesis
|
|
1.74
|
3.26e-02
|
GO:0072001
|
renal system development
|
|
1.74
|
3.26e-02
|
GO:2000241
|
regulation of reproductive process
|
|
1.41
|
3.37e-02
|
GO:0012502
|
induction of programmed cell death
|
|
1.51
|
3.40e-02
|
GO:0002253
|
activation of immune response
|
|
1.67
|
4.11e-02
|
GO:0051789
|
response to protein stimulus
|
|
1.41
|
4.14e-02
|
GO:0051603
|
proteolysis involved in cellular protein catabolic process
|
|
1.51
|
4.17e-02
|
GO:0048011
|
nerve growth factor receptor signaling pathway
|
|
1.43
|
4.20e-02
|
GO:0045860
|
positive regulation of protein kinase activity
|
|
1.32
|
4.35e-02
|
GO:0016071
|
mRNA metabolic process
|
|
1.49
|
4.40e-02
|
GO:0030168
|
platelet activation
|
|
1.57
|
4.40e-02
|
GO:0016570
|
histone modification
|
|
1.66
|
4.44e-02
|
GO:0043627
|
response to estrogen stimulus
|
|
1.56
|
4.57e-02
|
GO:0002757
|
immune response-activating signal transduction
|
|
1.56
|
4.57e-02
|
GO:0016569
|
covalent chromatin modification
|
|
1.85
|
4.66e-02
|
GO:0030178
|
negative regulation of Wnt receptor signaling pathway
|
|
1.56
|
4.74e-02
|
GO:0035239
|
tube morphogenesis
|
|
1.68
|
4.76e-02
|
GO:0014706
|
striated muscle tissue development
|
|
1.40
|
4.82e-02
|
GO:0006917
|
induction of apoptosis
|
